Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431's Potential as a Treatment for Chronic Liver Diseases

Stock Information for ContraVir Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.